Fluorine-18-fluorodeoxyglucose (FDG) positron emission tomography (PET) computed tomography (CT) for the detection of bone, lung, and lymph node metastases in rhabdomyosarcoma

CONCLUSIONS: The diagnostic accuracy of 18F-FDG-PET/CT for the detection of bone, lung, and lymph node metastases was reported in only two studies including a total of only 36 participants with newly diagnosed RMS. Because of the small number of studies (and participants), there is currently insufficient evidence to reliably determine the diagnostic accuracy of 18F-FDG-PET/CT in the detection of distant metastases. Larger series evaluating the diagnostic accuracy of 18F-FDG-PET/CT for the detection of metastases in patients with RMS are necessary.PMID:34753195 | DOI:10.1002/14651858.CD012325.pub2

Source: Cochrane Database of Systematic Reviews - November 9, 2021 Category: General Medicine Authors: Bas Vaarwerk Willemijn B Breunis Lianne M Haveman Bart de Keizer Nina Jehanno Lise Borgwardt Rick R van Rijn Henk van den Berg J érémie F Cohen Elvira C van Dalen Johannes Hm Merks Source Type: research